NCT07644975

Brief Summary

The goal of this clinical trial is to learn whether adjunctive electrolytic surface decontamination can improve the outcomes of surgical treatment of peri-implantitis. The main questions it aims to answer are:

  • Does electrolytic surface decontamination reduce probing pocket depth more effectively than conventional surgical treatment alone?
  • Does electrolytic surface decontamination improve bleeding on probing, suppuration, and radiographic bone levels? Researchers will compare conventional surgical treatment plus electrolytic surface decontamination with conventional surgical treatment alone. Participants will:
  • Receive surgical treatment for peri-implantitis
  • Be randomly assigned to one of the two treatment groups
  • Attend follow-up visits for clinical and radiographic examinations
  • Undergo assessment of probing pocket depth, bleeding on probing, suppuration, and bone level changes during follow-up

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
37mo left

Started Aug 2026

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 9, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 12, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2026

Expected
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2029

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2029

Last Updated

June 12, 2026

Status Verified

May 1, 2026

Enrollment Period

3 years

First QC Date

June 9, 2026

Last Update Submit

June 9, 2026

Conditions

Keywords

Peri-implantitisElectrolytic Surface DecontaminationImplant Surface Decontamination

Outcome Measures

Primary Outcomes (1)

  • Change in Probing Pocket Depth (PPD)

    Change in peri-implant probing pocket depth (PPD) measured in millimeters at treated implant sites. The difference between baseline and 24-month follow-up measurements will be evaluated.

    24 Months

Study Arms (2)

Conventional Surgical Treatment Alone

ACTIVE COMPARATOR

Participants assigned to this arm will receive conventional surgical treatment for peri-implantitis. Treatment will include flap elevation, mechanical implant surface decontamination using a titanium brush, and hydrogen peroxide application according to the study protocol.

Procedure: Conventional Surgical Treatment

Conventional Surgical Treatment Plus Electrolytic Surface Decontamination

EXPERIMENTAL

Participants assigned to this arm will receive conventional surgical treatment for peri-implantitis, including flap elevation, mechanical implant surface decontamination using a titanium brush. In addition, electrolytic surface decontamination will be performed according to the study protocol.

Procedure: Electrolytic Surface Decontamination

Interventions

Electrolytic implant surface decontamination performed using the GalvoSurge system as an adjunct to conventional surgical treatment. The procedure is intended to remove biofilm and contaminants from the implant surface through an electrolytic cleaning process.

Conventional Surgical Treatment Plus Electrolytic Surface Decontamination

Conventional surgical treatment of peri-implantitis consisting of flap elevation, mechanical implant surface decontamination using a titanium brush, and hydrogen peroxide application according to the study protocol.

Conventional Surgical Treatment Alone

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years or older Diagnosis of peri-implantitis requiring surgical treatment Presence of at least one dental implant diagnosed with peri-implantitis Ability and willingness to attend follow-up visits Provision of written informed consent

You may not qualify if:

  • Pregnancy or lactation Uncontrolled systemic diseases that may affect healing Immunosuppressive therapy History of head and neck radiotherapy Current use of medications known to affect bone metabolism Inability to comply with the study protocol or follow-up schedule Previous surgical treatment of peri-implantitis at the study implant site

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Istanbul University Faculty of Dentistry

Istanbul, Turkey (Türkiye)

Location

Istanbul University Faculty of Dentistry

Istanbul, Turkey (Türkiye)

Location

Related Publications (3)

  • Puisys A, Akhondi S, Vindasiute-Narbute E, Zvirblis T, Gallucci GO, Pedrinaci I. Peri-Implant Reconstruction With Autogenous Bone and Electrolytic Therapy: A Randomized Controlled Clinical Trial. Clin Implant Dent Relat Res. 2026 Apr;28(2):e70123. doi: 10.1111/cid.70123.

  • Monje A, Reffassi MS, Valles C, Gourdache I, Kumar P, Nart J. Understanding peri-implantitis occurrence and recurrence following treatment: A patient-centered study. J Periodontol. 2026 Apr 28. doi: 10.1002/jper.70133. Online ahead of print.

  • Arisan V, Saglanmak A, Anil A, Arici SV, Sculean A. Photodynamic Therapy as an Adjunct to Resective and Regenerative Surgical Treatment of Peri-Implantitis: A Prospective Cohort of 72 Patients Followed for 18 Months. Oral Health Prev Dent. 2025 Jun 3;23:305-314. doi: 10.3290/j.ohpd.c_2078.

MeSH Terms

Conditions

Peri-Implantitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Volkan Arısan, Professor

    Istanbul University Faculty of Dentistry

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Volkan Arısan, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 9, 2026

First Posted

June 12, 2026

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

August 1, 2029

Study Completion (Estimated)

August 1, 2029

Last Updated

June 12, 2026

Record last verified: 2026-05

Locations